UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION
	Washington, D.C. 20549
	SCHEDULE 13D/A

Under the Securities Exchange Act of 1934
(Amendment No. 6)*

(Name of Issuer)

 

(Title of Class of Securities)

 

(CUSIP Number)

 

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

^* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

2

 

 

3

 

 

4

 

This statement to Schedule 13D (this Statement) relates to a Schedule 13D filed on behalf of IDX System Corporation, a Vermont corporation (IDX), with the Securities and Exchange Commission (the SEC) on January 18, 2001 (the Original Schedule 13D), with respect to the Common Stock, par value $0.01 per share, of Allscripts Healthcare Solutions, Inc., a Delaware corporation (the Company), as amended by amendments to the Original Schedule 13D filed on March 20, 2002, February 28, 2005 and July 13, 2005, in each case, on behalf of IDX and IDX Investment Corporation, a Vermont corporation and wholly-owned subsidiary of IDX (IIC), and Amendment No. 4 filed on January 27, 2006 (Amendment No.4) and Amendment No. 5 filed on March 3, 2006, in each case, on behalf of General Electric Company, a New York corporation (General Electric), IDX and IIC (collectively, the Reporting Persons). As disclosed in Item 2 of Amendment No. 4,  IDX and IIC became wholly-owned subsidiaries of General Electric on January 4, 2006 as a result of an Agreement and Plan of Merger dated as of September 28, 2005, by and among General Electric, Igloo Acquisition Corporation, a Delaware corporation and a wholly-owned subsidiary of General Electric, and IDX (the IDX Merger).

 

Item 4 is hereby amended as follows:

 

Item 4.

Purpose of Transaction

 

5

 

On May 8, 2006, the Reporting Persons sold 3,397,375 shares of Common Stock of the Company at a price of $17.75 per share.
Item 5 is hereby amended as follows:
Item 5.	Interest in Securities of the Issuer
(a) - (b)  General Electric, IDX and IIC are beneficial owners of 2,429,763 shares of the Company's Common Stock and General Electric is, in addition, a beneficial owner of another 627 shares of the Company's Common Stock, which represents, in the aggregate, approximately 4.66% of the outstanding shares of Common Stock of the Company. 2,429,763 of these shares are owned directly by IIC, a wholly-owned subsidiary of IDX, which became a wholly-owned subsidiary of General Electric on January 4, 2006 as a result of the IDX Merger. General Electric and IDX are therefore indirect beneficial owners of 2,429,763 of these shares and have shared power to vote or to direct the vote, and shared power to dispose or to direct the disposition of, such shares. GE Healthcare Financial Services, a unit of General Electric, owns 627 shares of the Company's Common Stock and, as a result, General Electric has sole power to vote or to direct the vote, and sole power to dispose or to direct the disposition of, those shares. The beneficial ownership percentage amount reported above is based upon 52,083,351 shares of Common Stock of the Company issued and outstanding as of April 12, 2006, as reported by the Company in its proxy statement filed with the SEC on Schedule 14A on April 27, 2006.
(c) Except as described above in Item 4 and this Item 5, which are incorporated herein by reference, none of the Reporting Persons has effected any transactions in shares of Common Stock of the Company during the past 60 days.
(d) None.

 

6

 

(e) The Reporting Persons ceased to be the beneficial owners of more than 5% of the shares of Common Stock of the Company on May 8, 2006.

 

7

 

SIGNATURE

 

After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned hereby certify as of May 9, 2006 that the information set forth in this statement is true, complete and correct.

 

 

	General Electric Company
	By:	/s/ Barbara A. Lane
		Name: Barbara A. Lane
		Title: Attorney-In-Fact
	IDX Systems Corporation
	By:	/s/ Scott Mendel
		Name: Scott Mendel
		Title: Treasurer
	IDX Investment Corporation
	By:	/s/ Scott Mendel
		Name: Scott Mendel
		Title: Treasurer

 

8

 

EXHIBIT A

 

JOINT FILING STATEMENT

 

We, the undersigned, hereby express our agreement that the attached Amendment No.6 to Schedule 13D is hereby filed on behalf of each of us.

 

Dated:    May 9, 2006

 

	General Electric Company
	By:	/s/ Barbara A. Lane
		Name: Barbara A. Lane
		Title: Attorney-In-Fact
	IDX Systems Corporation
	By:	/s/ Scott Mendel
		Name: Scott Mendel
		Title: Treasurer
	IDX Investment Corporation
	By:	/s/ Scott Mendel
		Name: Scott Mendel
		Title: Treasurer

 

9